Matsuzaki H, Hata H, Sonoki T, Matsuno F, Kuribayashi N, Yoshida M, Nagasaki A, Murata H, Fujiyama S, Takatsuki K
Second Department of Internal Medicine, Kumamoto University School of Medicine, Japan.
Int J Hematol. 1995 Apr;61(3):131-7. doi: 10.1016/0925-5710(95)00359-z.
From October 1987 to November 1993 we evaluated the serum levels of ammonia and amino acids in 85 patients with multiple myeloma. Six of the 85 cases of multiple myeloma demonstrated hyperammonemia and none of the known causes of hyperammonemia, such as liver failure, could be identified in these patients. All six patients also showed serum amino acid disturbances and conscious disorders in various degrees. In this study we compared these abnormalities in multiple myeloma with those in chronic liver failure (n = 14), the basic diseases of which were liver cirrhosis in six cases and liver cirrhosis complicated hepatocellular carcinoma in eight cases. There was a marked difference in the levels of individual serum amino acids between these two groups. The level of glycine was significantly higher in the multiple myeloma group (P < 0.001); on the other hand, that of tyrosine was significantly higher in the liver failure group (P < 0.005). The histidine (P < 0.005) and arginine (P < 0.005) levels were lower in the myeloma group. The ratio of glycine to tyrosine (Gly/Tyr) was 16.7 +/- 4.85 in the myeloma group and 1.7 +/- 0.12 in the liver failure group. The ratio of glycine to tyrosine was an important criterion for differential diagnosis.
1987年10月至1993年11月,我们对85例多发性骨髓瘤患者的血清氨和氨基酸水平进行了评估。85例多发性骨髓瘤患者中有6例出现高氨血症,且在这些患者中未发现高氨血症的已知病因,如肝功能衰竭。所有6例患者还均表现出不同程度的血清氨基酸紊乱和意识障碍。在本研究中,我们将多发性骨髓瘤患者的这些异常情况与慢性肝功能衰竭患者(n = 14)进行了比较,慢性肝功能衰竭患者的基础疾病中6例为肝硬化,8例为肝硬化合并肝细胞癌。两组患者的血清单个氨基酸水平存在显著差异。多发性骨髓瘤组甘氨酸水平显著更高(P < 0.001);另一方面,肝功能衰竭组酪氨酸水平显著更高(P < 0.005)。骨髓瘤组组氨酸(P < 0.005)和精氨酸(P < 0.005)水平较低。骨髓瘤组甘氨酸与酪氨酸的比值(Gly/Tyr)为16.7 ± 4.85,肝功能衰竭组为1.7 ± 0.12。甘氨酸与酪氨酸的比值是鉴别诊断的重要标准。